Trending Topic

Stastical analysis indication diabetes mellitus .generative ai
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Saptarshi Bhattacharya, Sanjay Kalra, Lakshmi Nagendra

Very few trials in the history of medical science have altered the treatment landscape as profoundly as the UK Prospective Diabetes Study (UKPDS). Even 44 years after its inception, the trial and post-study follow-up findings continue to fascinate and enlighten the medical community. The study was conceived at a time when there was uncertainty about […]

3 mins

The Potential of Phosphorus Metabolic Magnetic Resonance Imaging and Spectroscopy for Assessing the Risk of Developing Foot Ulceration in Diabetes

Robert L Greenman
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 6th 2011 US Endocrinology, 2005;(1):51-4 DOI: http://doi.org/10.17925/USE.2005.00.01.51
Select a Section…
1

Abstract

Overview

The healthcare and social cost associated with diabetic peripheral neuropathy and the foot can be devastating. There are more than 300,000 hospitalizations in the US each year for diabetic foot complications and there were more than 92,000 lower extremity amputations of people with diabetes in 1999.1 The problems of ulceration and amputation have a profound effect on the quality of life of those who are affected.

2

Article

In diabetes, several specific pathologies contribute to the ulceration of the foot. Functional abnormalities of the microvasculature restrict the delivery of oxygen and other nutrients to the distal tissues of the extremities. The microvascular abnormalities include thickening of the capillary basement membrane,2 arteriovenous shunting,3 and a reduced vasodilatory capacity.4 These combined effects result in impaired soft tissue perfusion. Impaired perfusion has been associated with sensory, motor, and autonomic neuropathy.

In diabetes, several specific pathologies contribute to the ulceration of the foot. Functional abnormalities of the microvasculature restrict the delivery of oxygen and other nutrients to the distal tissues of the extremities. The microvascular abnormalities include thickening of the capillary basement membrane,2 arteriovenous shunting,3 and a reduced vasodilatory capacity.4 These combined effects result in impaired soft tissue perfusion. Impaired perfusion has been associated with sensory, motor, and autonomic neuropathy. The reduction in protective sensation caused by sensory neuropathy allows injury to occur without pain, leading to repetitive trauma that goes unnoticed by the patient, resulting in ulceration. The aforementioned microvascular abnormalities prevent adequate oxygen delivery to the injured area, preventing wounds from healing.The reduced perfusion in the muscle tissue can lead to atrophy and their replacement with fat and connective tissues. Foot muscle atrophy has been related to diabetic peripheral neuropathy in diabetic patients.5 Atrophy of the flexors and extensors is typically unequal and results in clawing of the toes, promoting the prominence of the metatarsal heads, which increases the pressures on the plantar aspect of the foot. This increases the patient’s vulnerability to the development of ulcers. In addition, atrophy and weakening of the plantar muscles reduces their effectiveness in protecting the foot against high mechanical pressures.

It is now understood that the complications that occur in the diabetic foot are not the result of occlusive disease of the small vessels but rather with peripheral diabetic neuropathy. Both conventional X-ray angiography and magnetic resonance angiography (MRA) are capable of identifying occlusive lesions but do not provide an assessment of the functionality of the vessels or their ability to deliver nutrients to local tissue beds. While the total blood flow in the lower limbs of diabetic patients can be adequate for maintaining healthy tissue, it is possible for the perfusion of the local tissues to be impaired.

In the muscle, the energy required for contraction and cellular maintenance functions is supplied by the hydrolysis of adenosine triphosphate (ATP) to adenosine diphosphate (ADP) and inorganic phosphate (Pi).The ATP moiety exists in very low concentrations (approximately four millimollar) in the myocytes and needs to be constantly replenished to maintain the health of the cell. This is accomplished by the creatine kinase reaction when phosphocreatine (PCr) donates its phosphorus atom to convert ADP to ATP. Phosphcreatine is the energy reservoir that maintains the ATP concentration at the level required to maintain cellular function.The reservoir of PCr is maintained by oxidative phosphorylation in the mitocondria, where creatine is converted back to PCr.This process is fueled by oxygen and glucose from the blood.When the tissue beds become ischemic, the supply of oxygen and other nutrients is inadequate for maintaining normal levels of PCr. In ischemic muscle tissue, the concentration of PCr is diminished while that of Pi increases. Under these conditions the concentration of ATP is easily depleted, resulting in the early onset of muscle fatigue and a compromised ability of the cells to carry out normal maintenance functions. If the ischemia persists or increases, the muscle cells eventually die and are replaced by fat and connective tissue. Functional abnormalities of the microvasculature are systemic, therefore the metabolic state of the foot muscles may be a surrogate for other tissues.

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup